Array CGH as a first line diagnostic test in place of karyotyping for postnatal referrals - results from four years’ clinical application for over 8,700 patients
Open Access
- 1 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Cytogenetics
- Vol. 6 (1), 16
- https://doi.org/10.1186/1755-8166-6-16
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The causality of de novo copy number variants is overestimatedEuropean Journal of Human Genetics, 2011
- Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal casesMolecular Cytogenetics, 2011
- Detection of mosaicism for genome imbalance in a cohort of 3,042 clinical cases using an oligonucleotide array CGH platformEuropean Journal of Medical Genetics, 2011
- De novo rates and selection of large copy number variationGenome Research, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- Validation and implementation of array comparative genomic hybridisation as a first line test in place of postnatal karyotyping for genome imbalanceMolecular Cytogenetics, 2010
- MLPA for confirmation of array CGH results and determination of inheritanceMolecular Cytogenetics, 2010
- Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcomeJournal of Medical Genetics, 2009
- Strategies for the rapid prenatal diagnosis of chromosome aneuploidyEuropean Journal of Human Genetics, 2004
- Detection of large-scale variation in the human genomeNature Genetics, 2004